Stakeholder Views Regarding a Health Impact Fund (HIF), to Incentivise Pharmaceutical Innovation Relevant to Diseases of Poverty

Coles, David, Ruto, Eric and Frewer, Lynn (2013) Stakeholder Views Regarding a Health Impact Fund (HIF), to Incentivise Pharmaceutical Innovation Relevant to Diseases of Poverty. GLOBAL HEALTH GOVERNANCE, VI (2). pp. 1-25. ISSN 1939-2389

Documents
Stakeholder Views Regarding a Health Impact Fund (HIF), to Incentivise Pharmaceutical Innovation Relevant to Diseases of Poverty
Accepted manuscript
[img]
[Download]
[img]
Preview
PDF
Coles, Ruto, and Frewer (2013)-Global Health Governance.pdf - Whole Document
Available under License Creative Commons Attribution-NonCommercial 4.0 International.

1MB
Item Type:Article
Item Status:Live Archive

Abstract

The HIF scheme, aims to create an alternative (Patent-2), to the existing Intellectual Property Rights (IPR) regime for rewarding pharmaceutical innovations through monopoly patents. Innovators would choose between the traditional IPR approach and the Patent-2 system to recoup innovation costs. Under Patent-2, reward would be based on the positive impact of the innovation on health globally. A two-stage, international, expert stakeholder Delphi survey (N=25) was conducted to identify stakeholder requirements for acceptance and implementation of Patent-2. Broad stakeholder support for the scheme was identified. Some practical issues were identified which require resolution. A larger survey (N=84 international stakeholders) was used to validate these findings. Results broadly corroborated the conclusions of the Delphi survey.

Keywords:Stakeholder participation, Health Impact Fund, Pharmaceutical Innovation, Diseases of Poverty, Delphi study
Subjects:L Social studies > L431 Health Policy
L Social studies > L360 Socio-economics
Divisions:Lincoln International Business School
Related URLs:
ID Code:48983
Deposited On:20 Apr 2022 10:43

Repository Staff Only: item control page